Learn more

SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD

Overview
  • Total Patents
    18
  • GoodIP Patent Rank
    94,069
About

SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD has a total of 18 patent applications. Its first patent ever was published in 2018. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are POMONA RICERCA SRL, I MAB BIOPHARMA US LTD and HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD.

Patent filings in countries

World map showing SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTDs patent filings in countries

Patent filings per year

Chart showing SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Zhu Min 18
#2 Wan Yakun 18
#3 Shen Xiaoning 18
#4 Ge Junwei 6
#5 Li Guanghui 4
#6 Gai Junwei 3
#7 Qiao Peng 1

Latest patents

Publication Filing date Title
CN112225807A anti-IL 5 nano antibody and application thereof
CN111718415A anti-TIGIT nano antibody and application thereof
CN111518212A anti-Trop 2 nano antibody and application thereof
CN111825766A anti-IL-4R single domain antibody and application thereof
CN110627906A anti-PD-L1/4-1 BB bispecific antibody and application thereof
CN110452297A Anti-vegf single domain antibody and its application
CN110835375A anti-PD-1/EGFR bispecific antibody and application thereof
CN110885376A anti-CD 47/CD20 bispecific antibodies and uses thereof
CN110885377A anti-CD 47/VEGF bispecific antibody and application thereof
CN110144011A For the single domain antibody of T lymphocyte immunoglobulin Mucin 3
CN110144009A CD47 single domain antibody and application thereof
CN110144010A Blocking-up type PD-L1 camel source single domain antibody and application thereof